This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This prespecified subgroup analysis of the FAME 3 randomized clinical trial investigates the relative treatment effect of fractional flow reserve (FFR)guided percutaneous coronary intervention vs coronaryarterybypassgraft according to diabetes status with respect to major adverse cardiac and cerebrovascular events at 3 years.
BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronaryarterybypassgrafting (CABG). Patients were categorized by diabetes status. PintHR=0.87) diabetes.
Left main coronaryartery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. However, the comparative long-term efficacy of percutaneous coronary intervention (PCI) versus coronaryarterybypassgrafting (CABG) in patients with these conditions remains unclear.
We evaluated the surgical outcomes in three groups of individuals with diabetes mellitus (DM), end-stage renal disease (ESRD), and on (ONCAB) vs. off-pump (OPCAB) coronaryarterybypassgrafting (CABG).
What are the outcomes in patients with left main disease with and without diabetes undergoing percutaneous coronary intervention (PCI) versus coronaryarterybypassgrafting (CABG)?
Objective To investigate the impact of prior coronaryarterybypassgrafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. Of these, 175 patients had a history of CABG, while 401 were free of CAD.
Subsequently, LASSO model was used to identify 11 important features, which were mechanical ventilation time, preoperative creatinine value, preoperative renal insufficiency, diabetes, the use of an intra-aortic balloon pump (IABP), age, Cardiopulmonary bypass time, Aortic cross-clamp time, Chronic Obstructive Pulmonary Disease (COPD) history, preoperative (..)
Remnant cholesterol (remnant-C) contributes to atherosclerotic cardiovascular disease (ASCVD), particularly in individuals with impaired glucose metabolism. Patients with impaired glu.
In this week’s View, Dr. Eagle looks at the difference between quantitative coronary angiography versus intervascular ultrasound to guide PCI. He then discusses paclitaxel-coated balloon catheters vs uncoated balloon angioplasty for treating coronary in-stent restenosis.
In many trials, revascularisation in addition to OMT was not effective in either improving survival or reducing adverse events compared with OMT alone, except for a subcohort of patients treated with coronaryarterybypassgrafting (CABG) in BARI-2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.
The overall prevalence of arterial hypertension was 33.2%, hyperlipidemia, 26.9%, smoking, 17.8%, and diabetes, 3.9%. The left anterior descending artery (LAD) was the most common culprit lesion in 51% of the patients. Results The systematic review included 13 observational studies evaluating 1,801 patients with SCAD.
Introduction The presence of non-coronary atherosclerosis (NCA) in patients with coronaryartery disease is associated with a poor prognosis. We have studied whether NCA is also a predictor of poorer outcomes in patients undergoing coronaryarterybypassgrafting (CABG).
Methods This study comprised prespecified and post-hoc analyses of the EMPA-REG OUTCOME trial in which 7020 people with type 2 diabetes (T2D) and cardiovascular disease [mostly atherosclerotic (ASCVD)] were randomized to empagliflozin or placebo and followed for a median 3.1 MIs could be assigned to > 1 type.
The secondary outcomes comprise the odds of adverse events, including myocardial infarction, ischemic stroke, transient ischemic attack (TIA), occlusive atherosclerotic disease, percutaneous coronary intervention, and coronaryarterybypassgraft (CABG)., The hemophilia cohort was slightly older (63.2[16.8]
Case Description:A 59-year-old male with history of hypertension, diabetes, Hashimoto’s thyroiditis presented with new, progressive shortness of breath. At the time of discharge, LV systolic function improved to 39% and there were no findings concerning for coronaryartery thrombosis or fistula repair failure.
As age advances and depending on risk factors like heredity, smoking, high blood pressure and diabetes, fat build up occurs in these blood vessels. This can block smooth flow of blood and the person can develop chest pain.
Conditions like preeclampsia, gestational diabetes, and hypertension during pregnancy are not only dangerous during pregnancy but also serve as indicators of future cardiovascular problems. Women who experience these complications should be vigilant about their heart health later in life.
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-ArterialCoronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency CoronaryArteryBypassGrafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
One of the most effective treatments for severe coronaryartery disease, a type of cardiovascular disease, is coronaryarterybypassgrafting (CABG), a procedure designed to restore blood flow to the heart. But does coronaryarterybypass surgery also improve erectile capacity?
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content